Dimerix Ltd (DXB)

Currency in AUD
0.215
-0.015(-6.52%)
Closed·
Unusual trading volume
Trading near 52-week Low
DXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2150.235
52 wk Range
0.2150.785
Key Statistics
Bid/Ask
0.215 / 0.22
Prev. Close
0.23
Open
0.23
Day's Range
0.215-0.235
52 wk Range
0.215-0.785
Volume
3.43M
Average Volume (3m)
1.53M
1-Year Change
-68.3824%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DXB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Dimerix Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
25-02-2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
2.12M / --
EPS Revisions
Last 90 days

DXB Income Statement

Compare DXB to Peers and Sector

Metrics to compare
DXB
Peers
Sector
Relationship
P/E Ratio
−7.9x−7.3x−0.5x
PEG Ratio
−0.22−0.030.00
Price/Book
−76.8x2.8x2.6x
Price / LTM Sales
17.4x12.0x3.2x
Upside (Analyst Target)
-112.0%47.8%
Fair Value Upside
Unlock−3.3%6.7%Unlock

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.15M2.02%2.61M
Other Institutional Investors
11.25M1.87%2.42M
Public Companies & Retail Investors
577.00M96.10%124.06M
Total
600.4M100.00%129.08M

FAQ

What Is the Dimerix (DXB) Share Price Today?

The Dimerix share price today is 0.215.

What is the current Dimerix (DXB) share price and day range?

As of 02-05-2026, the Dimerix share price is 0.215, with a previous close of 0.230. The share price has ranged from 0.215 to 0.235 today, while the 52-week range spans from 0.215 to 0.785.

What Is the Dimerix Market Cap?

As of today, Dimerix market cap is 129.090M.

What Is Dimerix's Earnings Per Share (TTM)?

The Dimerix EPS (TTM) is -0.028.

From a Technical Analysis Perspective, Is DXB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Dimerix Trade On?

Dimerix is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Dimerix?

The stock symbol for Dimerix is "DXB."

How Many Times Has Dimerix Stock Split?

Dimerix has split 10 times.

How Many Employees Does Dimerix Have?

Dimerix has 15 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.